Shanghai Pharmaceuticals Holding (601607.SH): Ceftriaxone sodium for injection passes consistency evaluation.

15:37 17/03/2026

Shanghai Pharmaceuticals (601607.SH) announced that its subsidiary, Shanghai Shang Yao Xin Ya Pharmaceutical Co., Ltd. (referred to as "Shang Yao Xin Ya"), has received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration for its injection of ceftriaxone sodium. This drug has passed the evaluation of generic drug quality and efficacy consistency. Ceftriaxone sodium for injection is used to treat respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, sepsis, infective endocarditis, hepatobiliary system infections, reproductive system infections, and perioperative prophylaxis infections caused by sensitive bacteria.

Shanghai Pharmaceuticals Holding (601607.SH) announced that its subsidiary Shanghai Shangyao Xinya Pharmaceutical Co., Ltd. (referred to as "Shangyao Xinya") has received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration for its injection form of Cefoperazone Sodium. This drug has passed the evaluation for consistency in quality and efficacy of generic drugs. Injection Cefoperazone Sodium is used to treat respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, sepsis, infective endocarditis, hepato-biliary system infections, reproductive system infections, and for perioperative prophylaxis.

TME-SW(01698) released its annual performance report, showing a net profit attributable to shareholders of 11.06 billion yuan, a year-on-year increase of 66.4%.

SHUNHO HOLDINGS (00253) expects the company's owners to enjoy a 26% increase in net profit after tax, excluding revaluations and non-cash depreciation, by the year 2025.

TME-SW(01698) will distribute annual dividends of $0.12 per share on April 20th.

TME-SW(01698) released its annual performance report, showing a net profit attributable to shareholders of 11.06 billion yuan, a year-on-year increase of 66.4%.

SHUNHO HOLDINGS (00253) expects the company's owners to enjoy a 26% increase in net profit after tax, excluding revaluations and non-cash depreciation, by the year 2025.

TME-SW(01698) will distribute annual dividends of $0.12 per share on April 20th.